CIK 0000882095 · Large accelerated filer
GILEAD SCIENCES, INC.
Sign in to watch- Ticker
- GILD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943047598
- Phone
- 6505743000
- Business address
- 333 LAKESIDE DR, FOSTER CITY, CA, 94404
- Former names
- GILEAD SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $39,503,648
- in 13 filings, $39.5M under 10b5-1 plans
Net −$39,503,648. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- O'Day Daniel Patrick −$29.5M Chairman & CEO sold 24% of stake
- Mercier Johanna −$4.8M Chief Comm & Corp Aff Officer sold 23% of stake
- WELTERS ANTHONY −$2.7M Director sold 58% of stake
- Dickinson Andrew D −$1.3M Chief Financial Officer sold 5% of stake
- Bluestone Jeffrey −$725K Director sold 33% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-06 | Cain Wettan Keeley M EVP Gen Counsel, Legal & Comp | Sale 10b5-1 | −3,399 | $164.11 | $558K | 5,360 |
| 2026-11-05 | O'Day Daniel Patrick Chairman & CEO | Option exercise 10b5-1 | +9,810 | $72.34 | $710K | 561,493 |
| 2026-11-05 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −9,810 | $175.17 | $1.7M | 551,683 |
| 2026-11-05 | O'Day Daniel Patrick Chairman & CEO | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −9,810 | 128,310 | ||
| 2026-11-04 | O'Day Daniel Patrick Chairman & CEO | Option exercise 10b5-1 | +102,619 | $72.34 | $7.4M | 654,302 |
| 2026-11-04 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −102,619 | $175.16 | $18.0M | 551,683 |
| 2026-11-04 | O'Day Daniel Patrick Chairman & CEO | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −102,619 | 138,120 | ||
| 2026-11-02 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −1,600 | $167.40 | $268K | 565,083 |
| 2026-11-02 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −1,700 | $168.10 | $286K | 563,383 |
| 2026-11-02 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −1,904 | $169.27 | $322K | 561,479 |
| 2026-11-02 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −7,796 | $170.35 | $1.3M | 553,683 |
| 2026-11-02 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −2,000 | $171.06 | $342K | 551,683 |
| 2026-10-30 | O'Day Daniel Patrick Chairman & CEO | Option exercise 10b5-1 | +15,881 | $72.34 | $1.1M | 582,564 |
| 2026-10-30 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −15,881 | $175.25 | $2.8M | 566,683 |
| 2026-10-30 | O'Day Daniel Patrick Chairman & CEO | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −15,881 | 240,739 | ||
| 2026-10-15 | Mercier Johanna Chief Comm & Corp Aff Officer | Sale 10b5-1 | −3,000 | $156.22 | $469K | 113,684 |
| 2026-10-15 | Dickinson Andrew D Chief Financial Officer | Sale 10b5-1 | −3,000 | $156.22 | $469K | 161,096 |
| 2026-10-01 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −12,000 | $147.72 | $1.8M | 569,683 |
| 2026-10-01 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −3,000 | $148.63 | $446K | 566,683 |
| 2026-09-22 | Burkhart Erin SVP, Controllership | Option exercise | +2,223 | 2,223 |
Page 1 of 14 · 277 trades